OrchiectomyProstatic Neoplasms, Castration-ResistantProstatic NeoplasmsProstateAndrogen AntagonistsReceptors, AndrogenCastrationTaxoidsCell Line, TumorDrug Resistance, NeoplasmProstate-Specific AntigenProstatic HyperplasiaAndrogensProstatectomyTransurethral Resection of ProstateProstatic Intraepithelial NeoplasiaGene Expression Regulation, NeoplasticAdenocarcinomaNeoplasms, Hormone-DependentDrug ResistanceTumor Cells, CulturedApoptosisDrug Resistance, MicrobialProstatic DiseasesTumor Markers, BiologicalDihydrotestosteroneMice, NudeMicrobial Sensitivity TestsCell ProliferationAnti-Bacterial AgentsTosyl CompoundsDisease ProgressionAntineoplastic AgentsDigital Rectal ExaminationFinasterideBone NeoplasmsImmunohistochemistryNeoplasm GradingAndrogen Receptor AntagonistsReverse Transcriptase Polymerase Chain ReactionRNA, MessengerProstatitisNeoplasm MetastasisSignal TransductionMutationBrachytherapyTime FactorsAnilides5-alpha Reductase InhibitorsMolecular Sequence DataSeminal VesiclesNeoplasm StagingAntineoplastic Agents, HormonalCase-Control StudiesTestosteroneDrug Resistance, BacterialXenograft Model Antitumor AssaysWatchful WaitingNeoplasm ProteinsFlutamideMetriboloneNeoplasm TransplantationCell SurvivalBlotting, WesternBiopsy, NeedleCell DivisionBiopsyTransplantation, HeterologousRisk FactorsAzasteroidsEpithelial CellsTreatment OutcomeGlutamate Carboxypeptidase IIBase SequenceNeoplasm InvasivenessGenetic Predisposition to DiseaseGenotypeDose-Response Relationship, DrugGene Expression ProfilingPrognosis3-Oxo-5-alpha-Steroid 4-DehydrogenaseTransfectionPTEN PhosphohydrolaseDown-RegulationCell LineCholestenone 5 alpha-ReductaseSensitivity and SpecificityCarcinomaMice, SCIDTestosterone CongenersPolymerase Chain ReactionCell Growth ProcessesAndrogen-Binding ProteinDrug Resistance, MultipleRNA, Small InterferingMice, Inbred C57BLPhenotypeRadiotherapy, ConformalRectumAnticarcinogenic Agents